Crystal structure of the complex of group I PLA 2 with a group II-specific peptide Leu-Ala-Ile-Tyr-Ser (LAIYS) at 2.6 Å resolution

By Singh Rajendra K.   Singh Nagendra   Jabeen Talat   Sharma Sujata   Dey Sharmistha   Singh T. P.  

Journal of Drug Targeting, Vol. 13, Iss. 6, 2005-07 ,pp. : 367-374

Informa Healthcare

Access to resources Recommend Favorite

Oxazole- and Imidazole-Based Ser-Leu Dipeptide Mimetics in Potent Inhibitors of Antigen Presentation by MHC Class II DR Molecules

By Sarabu Ramakanth   Bolin David R.   Campbell Robert   Cooper Joel P.   Cox Donald   Gaizband Diana   Makofske Raymond   Nagy Zoltan   Olson Gary L.  

Drug Design and Discovery, Vol. 18, Iss. 1, 2002-03 ,pp. : 3-7

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes

By Holstein Judith Dina   Kovacs Peter   Patzer Olaf   Stumvoll Michael   Holstein Andreas  

Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. : 5-7

Future Medicine

Access to resources Recommend Favorite

Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 3, 2004-07 ,pp. : 247-255

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy

By Ibsen Stuart   Zahavy Eran   Wrasdilo Wolf   Berns Michael   Chan Michael   Esener Sadik  

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 1848-1860

Springer Publishing Company

Access to resources Recommend Favorite